Learn More
Medchemexpress LLC Iniparib (BSI-201) | 160003-66-7 | 99.7% | 200 MG

Supplier: Medchemexpress LLC HY12015200MG
Iniparib (BSI-201) is an irreversible poly(ADP-ribose) polymerase 1 (PARP1) inhibitor supplied for research use. It is used in preclinical and translational studies, notably in triple-negative breast cancer research, and is provided as a purified solid suitable for laboratory experiments.
- Irreversible inhibitor of PARP1.
- Commonly used in triple-negative breast cancer research.
- Supplied as a high-purity research-grade compound.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.